HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen S Flatten Selected Research

tapotoclax

3/2024AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen S Flatten Research Topics

Disease

19Neoplasms (Cancer)
03/2024 - 12/2005
8Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 09/2008
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 01/2010
5Leukemia
03/2024 - 11/2011
4Carcinoma (Carcinomatosis)
11/2021 - 09/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 01/2012
2Breast Neoplasms (Breast Cancer)
10/2021 - 12/2008
2Lymphoma (Lymphomas)
01/2014 - 01/2012
2Ataxia Telangiectasia (Louis Bar Syndrome)
10/2012 - 12/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2009 - 09/2008
1Hypersensitivity (Allergy)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014
1Myeloid Leukemia (Leukemia, Myelocytic)
07/2014
1Poisoning
02/2012
1Sezary Syndrome (Sezary Erythroderma)
01/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2012
1Disseminated Intravascular Coagulation
11/2011
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2011
1Myocardial Infarction
11/2011
1Neoplasm Metastasis (Metastasis)
11/2010

Drug/Important Bio-Agent (IBA)

9Poly(ADP-ribose) Polymerase InhibitorsIBA
09/2021 - 02/2012
7Phosphotransferases (Kinase)IBA
01/2016 - 12/2005
5Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2008
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019 - 11/2011
4DNA (Deoxyribonucleic Acid)IBA
01/2019 - 09/2008
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019 - 03/2012
3veliparibIBA
01/2018 - 06/2013
3Topotecan (Hycamtin)FDA LinkGeneric
01/2018 - 12/2008
3MK-8776IBA
04/2014 - 10/2012
3GemcitabineFDA Link
06/2013 - 12/2005
3Checkpoint Kinase 1IBA
10/2012 - 12/2005
2venetoclaxIBA
04/2024 - 10/2021
2navitoclaxIBA
03/2024 - 10/2021
2Antineoplastic Agents (Antineoplastics)IBA
03/2024 - 05/2014
2S63845IBA
03/2024 - 10/2021
2Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 11/2016
2EnzymesIBA
10/2021 - 02/2012
2niraparibIBA
09/2021 - 11/2016
2LigandsIBA
01/2021 - 01/2010
2TOR Serine-Threonine KinasesIBA
01/2016 - 01/2012
2Cisplatin (Platino)FDA LinkGeneric
05/2014 - 06/2013
2tanespimycin (17AAG)IBA
11/2011 - 11/2010
2Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2011 - 11/2010
1Azacitidine (5 Azacytidine)FDA Link
04/2024
1pevonedistatIBA
04/2024
1tapotoclaxIBA
03/2024
1dorsomorphinIBA
03/2024
1Adenylate KinaseIBA
03/2024
1sapanisertibIBA
11/2023
1Taxoids (Taxanes)IBA
11/2021
1Deubiquitinating EnzymesIBA
11/2021
1taxaneIBA
11/2021
1PlatinumIBA
11/2021
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
10/2021
1PalmitatesIBA
10/2021
1NADP (NADPH)IBA
10/2021
1rucaparibIBA
09/2021
1ABT-767IBA
01/2019
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2019
1CPX-351IBA
01/2019
1Carboplatin (JM8)FDA LinkGeneric
11/2016
1trioctyl phosphine oxide (TOPO)IBA
04/2016
1Death Domain ReceptorsIBA
07/2014
1olaparibIBA
07/2014
1AminesIBA
05/2014
1CamptothecinIBA
05/2014
1Adenosine Triphosphate (ATP)IBA
05/2014
1Etoposide (VP 16)FDA LinkGeneric
05/2014
1MK 2206IBA
05/2014
1Melphalan (Alkeran)FDA LinkGeneric
05/2014
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2014
1A 443654IBA
05/2014
1Small Interfering RNA (siRNA)IBA
05/2014
1adavosertibIBA
04/2014
1Farnesyltranstransferase (Farnesyltransferase)IBA
01/2014
1tipifarnib (R115777)IBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Topoisomerase I InhibitorsIBA
02/2012
1OSI 027IBA
01/2012
1Mechanistic Target of Rapamycin Complex 1IBA
01/2012
1Mechanistic Target of Rapamycin Complex 2IBA
01/2012
1Sirolimus (Rapamycin)FDA Link
01/2012
117-aminogeldanamycinIBA
11/2011
1Oncogene Proteins (Oncogene Protein)IBA
11/2010
1Long-Acting Thyroid Stimulator (LATS)IBA
11/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010
1enzastaurinIBA
01/2010
1Type I DNA Topoisomerases (Topoisomerase I)IBA
08/2009
1PoisonsIBA
08/2009
1Type II DNA Topoisomerases (Topoisomerase II)IBA
08/2009
1ErbB Receptors (EGF Receptor)IBA
12/2008
1Lapatinib (GW572016)FDA Link
12/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2008
1Irinotecan (Camptosar)FDA LinkGeneric
09/2008
1Checkpoint Kinase 2IBA
12/2005
1Protein Kinases (Protein Kinase)IBA
12/2005

Therapy/Procedure

4Therapeutics
10/2021 - 08/2009
2Drug Therapy (Chemotherapy)
11/2021 - 06/2013
1Oral Administration
10/2021
1Aftercare (After-Treatment)
12/2005